ISMPP (pronounced IzMap) is the only not-for-profit organization founded by medical publication professionals for medical publication professionals
Since its inception in 2005, our membership has grown to more than 1,400 with representation from all stakeholders involved in the publication of medical research, including pharmaceutical, biotechnology, and device companies, medical publications and communications agencies, medical journal publishers and editors, and professional medical writers.
Click here to view the many benefits of membership.
And to our members, thank you for your ongoing support.
ISMPP: A Decade of Achievements slide resource
Please use the link below to access ISMPP: A Decade of Achievements, a slide presentation developed by the ISMPP Ethics Committee to provide valuable information about all that ISMPP offers its members, and encourage involvement in ISMPP activities. Further, this resource can support requests for financial assistance for membership, attendance at annual meetings or workshops, corporate sponsorship, or to demonstrate the value of volunteer participation on committees.
According to Yvonne Yarker, Immediate Past Chair of the Ethics Committee, ‘‘This slide resource provides a historical overview of ISMPP and its evolution to become a recognized international professional society, and highlights the many significant achievements that ISMPP has made over its first 10 years.’’
We greatly appreciate our members and trust that this resource will help to demonstrate the considerable achievements of ISMPP, our continued progress, and the exceptional value of ISMPP membership.
APET ISMPP U: Waking the Sleeping Tiger: Overview of Clinical Trials and Publication Practices in India
Tuesday, July 14 , 2015
Waking the Sleeping Tiger: Overview of Clinical Trials and Publication Practices in India
Ajit Nair, PhD - Head Global Medical and Clinical Services, Novartis Healthcare Pvt. Ltd., Hyderabad, India
Moderator: Kanaka Sridharan, MS, RPh, ISMPP CMPP™ – Global Head Scientific Communications, Cell & Gene Therapies Unit, Novartis Pharmaceuticals, East Hanover, NJ, USA
To listen to the audio and slide presentation, click on the following link: http://login.icohere.com/ISMPP?pnum=NQD43553